Eton Pharmaceuticals, Inc.（ETON）内部人交易：高管与董事近期交易
过去 18 个月，共有 8 位内部人为 Eton Pharmaceuticals, Inc.（ETON）报告了 65 笔 Form 4 交易（最近一笔 2026-10-06）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-06 | Krempa David | Chief Business Officer | 卖出 | 4,166 | $229,406 |
| 2026-10-06 | Krempa David | Chief Business Officer | 买入 | 10,522 | $0 |
| 2026-08-31 | MAIER PAUL V | 董事 | 卖出 | 36,387 | $2.1M |
| 2026-08-31 | MAIER PAUL V | 董事 | 买入 | 50,000 | $189,000 |
| 2026-08-31 | MAIER PAUL V | 董事 | 卖出 | 13,485 | $811,932 |
| 2026-08-31 | MAIER PAUL V | 董事 | 卖出 | 128 | $7,907 |
| 2026-08-31 | MAIER PAUL V | 董事 | 买入 | 12,500 | $91,375 |
| 2026-08-28 | MAIER PAUL V | 董事 | 买入 | 50,000 | $189,000 |
| 2026-08-28 | MAIER PAUL V | 董事 | 卖出 | 36,387 | $2.1M |
| 2026-08-28 | MAIER PAUL V | 董事 | 卖出 | 13,485 | $811,932 |
| 2026-08-28 | MAIER PAUL V | 董事 | 卖出 | 128 | $7,907 |
| 2026-08-24 | Krempa David | Chief Business Officer | 卖出 | 25,000 | $1.6M |
| 2026-08-24 | Krempa David | Chief Business Officer | 买入 | 25,000 | $182,750 |
| 2026-08-20 | BRYNJELSEN SEAN | President & CEO | 卖出 | 8,978 | $562,472 |
| 2026-08-20 | BRYNJELSEN SEAN | President & CEO | 卖出 | 47,307 | $2.8M |
| 2026-08-20 | BRYNJELSEN SEAN | President & CEO | 卖出 | 36,373 | $2.2M |
| 2026-08-20 | BRYNJELSEN SEAN | President & CEO | 卖出 | 7,342 | $456,085 |
| 2026-07-17 | Opaleye Management Inc. | 10% 以上股东 | 卖出 | 15,000 | $563,146 |
| 2026-07-17 | Opaleye Management Inc. | 10% 以上股东 | 卖出 | 13,315 | $499,886 |
| 2026-07-16 | Opaleye Management Inc. | 10% 以上股东 | 卖出 | 15,000 | $563,146 |
| 2026-07-16 | Opaleye Management Inc. | 10% 以上股东 | 卖出 | 13,315 | $499,886 |
| 2026-07-14 | BRYNJELSEN SEAN | President & CEO | 买入 | 27,500 | $0 |
| 2026-07-14 | BRYNJELSEN SEAN | President & CEO | 买入 | 200,000 | $274,000 |
| 2026-07-13 | Krempa David | Chief Business Officer | 买入 | 10,000 | $0 |
| 2026-07-07 | Opaleye Management Inc. | 10% 以上股东 | 卖出 | 65,000 | $2.4M |
来源：SEC Form 4 申报文件 · 截至 2026-10-06